Aximris XR FDA Approval Status
Last updated by Judith Stewart, BPharm on Jan 30, 2020.
FDA Approved: No
Brand name: Aximris XR
Generic name: oxycodone hydrochloride
Dosage form: Extended-Release Tablets
Previous Name: Rexista
Company: Intellipharmaceutics International Inc.
Treatment for: Pain
Aximris XR (oxycodone hydrochloride extended release) is an abuse and alcohol-deterrent controlled-release formulation of oxycodone hydrochloride in development for the relief of moderate to severe pain.
Development Timeline for Aximris XR
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.